1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
EULAR recommendations for the management of ANCA-associated vasculitis : 2022 update
- Contribution to journal › Article
- 2023
-
Mark
Risk Factors for Primary Bone Cancer After Childhood Cancer : A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study
(2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(21). p.3735-3746
- Contribution to journal › Article
-
Mark
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
- Contribution to journal › Article
- 2022
-
Mark
The management of membranous nephropathy—an update
- Contribution to journal › Article
-
Mark
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- Contribution to journal › Article
- 2018
-
Mark
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome
- Contribution to journal › Article
- 2017
-
Mark
Treatment outcome in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study (ESOS)
- Contribution to journal › Article
- 2014
-
Mark
Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness.
- Contribution to journal › Article
-
Mark
Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review
- Contribution to journal › Scientific review
- 2010
-
Mark
Radiotherapy in Early Breast Cancer
- Thesis › Doctoral thesis (compilation)
